Advanced search
Publication Cover
Emerging Microbes & Infections Volume 7, 2018 - Issue 1
Submit an article Journal homepage
2,983
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro

Minxi WeiState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life SciencesXiamen University361102XiamenChina
,
Daning WangNational Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public HealthXiamen University361102XiamenChina
,
Zhihai LiState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life SciencesXiamen University361102XiamenChina
,
Shuo SongState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life SciencesXiamen University361102XiamenChina
,
Xianglin KongState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life SciencesXiamen University361102XiamenChina
,
Xiaobing MoState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life SciencesXiamen University361102XiamenChina
,
Yurou YangState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life SciencesXiamen University361102XiamenChina
,
Maozhou HeNational Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public HealthXiamen University361102XiamenChina
,
Zhongyi LiXiamen Innovax Biotech Company, Ltd361022XiamenChina
,
Bo HuangXiamen Innovax Biotech Company, Ltd361022XiamenChina
,
Zhijie LinXiamen Innovax Biotech Company, Ltd361022XiamenChina
,
Huirong PanXiamen Innovax Biotech Company, Ltd361022XiamenChina
,
Qingbing ZhengNational Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public HealthXiamen University361102XiamenChina
,
Hai YuNational Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public HealthXiamen University361102XiamenChina
,
Ying GuState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life SciencesXiamen University361102XiamenChina;National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public HealthXiamen University361102XiamenChina
,
Jun ZhangNational Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public HealthXiamen University361102XiamenChina
,
Shaowei LiState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life SciencesXiamen University361102XiamenChina;National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public HealthXiamen University361102XiamenChinaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3374-1038
ORCID Icon &
Ningshao XiaState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life SciencesXiamen University361102XiamenChina;National Institute of Diagnostics and Vaccine Development in Infectious Disease, School of Public HealthXiamen University361102XiamenChinaCorrespondence[email protected]
 show all
Pages 1-12 | Received 16 Jun 2018, Accepted 28 Aug 2018, Published online: 26 Sep 2018

References

  • CubieHADiseases associated with human papillomavirus infectionVirology2013445 21 3410.1016/j.virol.2013.06.007
  • LiZHLiPEvaluation of tributyltin toxicity in Chinese rare minnow larvae by abnormal behavior, energy metabolism and endoplasmic reticulum stressChem. Biol. Interact.2015227323610.1016/j.cbi.2014.12.010
  • de VilliersEMCross-roads in the classification of papillomavirusesVirology201344521010.1016/j.virol.2013.04.023
  • MunozNCastellsagueXde GonzalezABGissmannLChapter 1: HPV in the etiology of human cancerVaccine200624Suppl 3S3/1S3/10
  • BurchellANWinerRLde SanjoseSFrancoELChapter 6: Epidemiology and transmission dynamics of genital HPV infectionVaccine200624Suppl 3S3/52S3/561
  • CliffordGMHuman papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBr. J. Cancer200388637310.1038/sj.bjc.6600688
  • de SanjoseSHuman papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyLancet Oncol.2010111048105610.1016/S1470-2045(10)70230-8
  • SerranoBPotential impact of a nine-valent vaccine in human papillomavirus related cervical diseaseInfect. Agent Cancer2012710.1186/1750-9378-7-38
  • GarlandSMNatural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccineJ. Infect. Dis.200919980581410.1086/597071
  • GarlandSMQuadrivalent vaccine against human papillomavirus to prevent anogenital diseasesN. Engl. J. Med.20073561928194310.1056/NEJMoa061760
  • VesikariTA randomized, double-blind, phase III study of the immunogenicity and safety of a 9-valent human papillomavirus L1 virus-like particle vaccine (V503) versus Gardasil(R) in 9-15-year-old girlsPediatr. Infect. Dis. J.20153499299810.1097/INF.0000000000000773
  • PaavonenJEfficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trialLancet20073692161217010.1016/S0140-6736(07)60946-5
  • HagenseeMEOlsonNHBakerTSGallowayDAThree-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsidsJ. Virol.19946845034505236376
  • BuckCBArrangement of L2 within the papillomavirus capsidJ. Virol.2008825190519710.1128/JVI.02726-07
  • NeeperMPHofmannKJJansenKUExpression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisaeGene19961801610.1016/S0378-1119(96)00388-5
  • ShchelkunovSNThe genomic sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteinsVirology199824343246010.1006/viro.1998.9039
  • RoseRCReichmanRCBonnezWHuman papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human seraJ. Gen. Virol.199475Pt 82075207910.1099/0022-1317-75-8-2075
  • SchillerJTLowyDRPapillomavirus-like particles and HPV vaccine developmentSemin. Cancer Biol.1996737338210.1006/scbi.1996.0046
  • KimSNJeongHSParkSNKimHJPurification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiaeJ. Virol. Methods2007139243010.1016/j.jviromet.2006.09.004
  • SengerTSchadlichLGissmannLMullerMEnhanced papillomavirus-like particle production in insect cellsVirology200938834435310.1016/j.virol.2009.04.004
  • ZhangWExpression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitroVirology199824342343110.1006/viro.1998.9050
  • SchadlichLRefining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicityVaccine2009271511152210.1016/j.vaccine.2009.01.014
  • LiSWA bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primatesVaccine2005232893290110.1016/j.vaccine.2004.11.064
  • MaZIncreasing the expression levels of papillomavirus major capsid protein in Escherichia coli by N-terminal deletionProtein Expr. Purif.200756727910.1016/j.pep.2007.05.010
  • ThonesNA direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than virus-like particles with respect to the induced antibody responseJ. Virol.2008825472548510.1128/JVI.02482-07
  • YuanHImmunization with a pentameric L1 fusion protein protects against papillomavirus infectionJ. Virol.2001757848785310.1128/JVI.75.17.7848-7853.2001
  • ChenXSCasiniGHarrisonSCGarceaRLPapillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV 16 L1J. Mol. Biol.200130717318210.1006/jmbi.2000.4464
  • KelsallSRKulskiJKExpression of the major capsid protein of human papillomavirus type 16 in Escherichia coliJ. Virol. Methods199553759010.1016/0166-0934(95)00004-E
  • BanksLExpression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterizationJ. Gen. Virol.198768Pt 123081308910.1099/0022-1317-68-12-3081
  • JenisonSAFirzlaffJMLangenbergAGallowayDAIdentification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteinsJ. Virol.19886221152123253307
  • VarsaniAWilliamsonALJafferMARybickiEPA deletion and point mutation study of the human papillomavirus type 16 major capsid geneVirus Res.200612215416310.1016/j.virusres.2006.07.012
  • SchadlichLAnalysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicityJ. Virol.2009837690770510.1128/JVI.02588-08
  • CollierBObergDZhaoXSchwartzSSpecific inactivation of inhibitory sequences in the 5’ end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cellsJ. Virol.2002762739275210.1128/JVI.76.6.2739-2752.2002
  • WangDStop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coliProtein Expr. Purif.201713311012010.1016/j.pep.2017.03.003
  • PanHBacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: characterization, antigenicity and immunogenicityVaccine2017353222323110.1016/j.vaccine.2017.04.064
  • GuYCharacterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccineVaccine2017354637464510.1016/j.vaccine.2017.06.084
  • GuanJCryoelectron microscopy maps of human papillomavirus 16 reveal L2 densities and heparin binding siteStructure20172525326310.1016/j.str.2016.12.001
  • ZhangXRobust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin((R)Vaccine2014324039405010.1016/j.vaccine.2014.05.064
  • DeschuyteneerMMolecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccineHum. Vaccin.2010640741910.4161/hv.6.5.11023
  • ZhaoQCharacterization of virus-like particles in GARDASIL(R) by cryo transmission electron microscopyHum. Vaccin. Immunother.20141073473910.4161/hv.27316
  • LiZThe C-terminal arm of the human papillomavirus major capsid protein is immunogenic and involved in virus-host interactionStructure20162487488510.1016/j.str.2016.04.008
  • WolfMGarceaRLGrigorieffNHarrisonSCSubunit interactions in bovine papillomavirusProc. Natl Acad. Sci. USA20101076298630310.1073/pnas.0914604107
  • ReedLJM. H. A simple method of estimating fifty percent endpointsAm. J. Hyg.193827493497
  • JouraEAA 9-valent HPV vaccine against infection and intraepithelial neoplasia in womenN. Engl. J. Med.201537271172310.1056/NEJMoa1405044
  • SchwartzSRegulation of human papillomavirus late gene expressionUps J. Med. Sci.2000105171192
  • Hanumantha RaoNExpression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particlesVaccine2011297326733410.1016/j.vaccine.2011.07.071
  • HuYPackaging of a polymer by a viral capsid: the interplay between polymer length and capsid sizeBiophys. J.2008941428143610.1529/biophysj.107.117473
  • LuoWXConstruction and application of an Escherichia coli high effective expression vector with an enhancerSheng Wu Gong. Cheng Xue Bao 200016578581
  • ChristensenNDMonoclonal antibody-mediated neutralization of infectious human papillomavirus type 11J. Virol.19906456785681248629
  • ZamZSJonesPDasNDProduction of hybridomas secreting antibodies to the corneaCurr. Eye Res.1981113914410.3109/02713688109001819
  • GuYStructural basis for the neutralization of hepatitis E virus by a cross-genotype antibodyCell Res.20152560462010.1038/cr.2015.34
  • YanXSinkovitsRSBakerTSAUTO3DEM—an automated and high throughput program for image reconstruction of icosahedral particlesJ. Struct. Biol.2007157738210.1016/j.jsb.2006.08.007
  • TangGEMAN2: an extensible image processing suite for electron microscopyJ. Struct. Biol.2007157384610.1016/j.jsb.2006.05.009
  • ScheresSHRELION: implementation of a Bayesian approach to cryo-EM structure determinationJ. Struct. Biol.201218051953010.1016/j.jsb.2012.09.006
  • KondoKNeutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface regionVirology200735826627210.1016/j.virol.2006.08.037
  • BuckCBPastranaDVLowyDRSchillerJTEfficient intracellular assembly of papillomaviral vectorsJ. Virol.20047875175710.1128/JVI.78.2.751-757.2004
  • PastranaDVReactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18Virology200432120521610.1016/j.virol.2003.12.027
  • BuckCBPastranaDVLowyDRSchillerJTGeneration of HPV pseudovirions using transfection and their use in neutralization assaysMethods Mol. Med.2005119445462
  • ChenYAntigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicityVaccine20133142543010.1016/j.vaccine.2012.10.032

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.